Neurologic Manifestations of the World Health Organization's List of Pandemic and Epidemic Diseases
Open Access
- 22 February 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
Abstract
The World Health Organization (WHO) monitors the spread of diseases globally and maintains a list of diseases with epidemic or pandemic potential. Currently listed diseases include Chikungunya, cholera, Crimean-Congo hemorrhagic fever, Ebola virus disease, Hendra virus infection, influenza, Lassa fever, Marburg virus disease, Neisseria meningitis, MERS-CoV, monkeypox, Nipah virus infection, novel coronavirus (COVID-19), plague, Rift Valley fever, SARS, smallpox, tularemia, yellow fever, and Zika virus disease. The associated pathogens are increasingly important on the global stage. The majority of these diseases have neurological manifestations. Those with less frequent neurological manifestations may also have important consequences. This is highlighted now in particular through the ongoing COVID-19 pandemic and reinforces that pathogens with the potential to spread rapidly and widely, in spite of concerted global efforts, may affect the nervous system. We searched the scientific literature, dating from 1934 to August 2020, to compile data on the cause, epidemiology, clinical presentation, neuroimaging features, and treatment of each of the diseases of epidemic or pandemic potential as viewed through a neurologist's lens. We included articles with an abstract or full text in English in this topical and scoping review. Diseases with epidemic and pandemic potential can be spread directly from human to human, animal to human, via mosquitoes or other insects, or via environmental contamination. Manifestations include central neurologic conditions (meningitis, encephalitis, intraparenchymal hemorrhage, seizures), peripheral and cranial nerve syndromes (sensory neuropathy, sensorineural hearing loss, ophthalmoplegia), post-infectious syndromes (acute inflammatory polyneuropathy), and congenital syndromes (fetal microcephaly), among others. Some diseases have not been well-characterized from a neurological standpoint, but all have at least scattered case reports of neurological features. Some of the diseases have curative treatments available while in other cases, supportive care remains the only management option. Regardless of the pathogen, prompt, and aggressive measures to control the spread of these agents are the most important factors in lowering the overall morbidity and mortality they can cause.Keywords
This publication has 241 references indexed in Scilit:
- Accuracy of real-time PCR, Gram stain and culture for Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae meningitis diagnosisBMC Infectious Diseases, 2013
- Review of Two Decades of Cholera Diagnostics – How Far Have We Really Come?PLoS Neglected Tropical Diseases, 2012
- The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigensVaccine, 2012
- Improved Detection of Lassa Virus by Reverse Transcription-PCR Targeting the 5′ Region of S RNAJournal of Clinical Microbiology, 2010
- Chloroquine Administration Does Not Prevent Nipah Virus Infection and Disease in FerretsJournal of Virology, 2009
- Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infectionJournal of General Virology, 2009
- Sensorineural hearing loss in Lassa fever: two case reportsJournal of Medical Case Reports, 2009
- Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2Journal of Virology, 2008
- Cognitive outcome in adults after bacterial meningitisJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Harvesting can increase severity of wildlife disease epidemicsProceedings. Biological sciences, 2006